94-13505. Agency for Toxic Substances and Disease Registry  

  • [Federal Register Volume 59, Number 106 (Friday, June 3, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-13505]
    
    
    [[Page Unknown]]
    
    [Federal Register: June 3, 1994]
    
    
    -----------------------------------------------------------------------
    
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
     
    
    Agency for Toxic Substances and Disease Registry
    
    [Program Announcement Number 444]
    
    Health Studies Related to the National Exposure Registry
    
    Introduction
    
        The Agency for Toxic Substances and Disease Registry (ATSDR) 
    announces the availability of fiscal year (FY) 1994 funds for a 
    cooperative agreement/grant program to conduct health studies of 
    trichloroethylene (TCE)-exposed subpopulations that comprise the TCE 
    Subregistry of the National Exposure Registry. The studies will address 
    health conditions identified by ATSDR as potential health conditions 
    associated with environmental exposure to TCE, with emphasis on 
    neurotoxic disorders. The recipient will utilize the National Exposure 
    Registry Trichloroethylene (TCE) Subregistry database in designing and 
    executing these studies.
        The Public Health Service (PHS) is committed to achieving the 
    health promotion and disease prevention objectives of ``Healthy People 
    2000,'' a PHS-led national activity to reduce morbidity and mortality 
    and improve the quality of life. This announcement is related to the 
    priority area of Environmental Health. (For ordering a copy of 
    ``Healthy People 2000,'' see the section Where to Obtain Additional 
    Information.)
    
        Authority: This program is authorized under sections 
    104(i)(1)(E),(7), and (15) of the Comprehensive Environmental 
    Response, Compensation, and Liability Act (CERCLA) of 1980 as 
    amended by the Superfund Amendments and Reauthorization Act (SARA) 
    of 1986, (42 U.S.C. 9604 (i)(1)(E),(7), and (15)).
    
    Smoke-Free Workplace
    
        The PHS strongly encourages all grant recipients to provide a 
    smoke-free workplace and promote the non-use of all tobacco products. 
    This is consistent with the PHS mission to protect and advance the 
    physical and mental health of the American People.
    
    Eligible Applicants
    
        Eligible applicants are the official public health agencies of 
    States or their bona fide agents. This includes the District of 
    Columbia, American Samoa, the Commonwealth of Puerto Rico, the Virgin 
    Islands, the Federated States of Micronesia, Guam, the Northern Mariana 
    Islands, the Republic of the Marshall Islands, the Republic of Palau, 
    and federally-recognized Indian tribal governments. State 
    organizations, including State universities, State colleges, and State 
    research institutions, must establish that they meet their respective 
    State's legislature definition of a State entity or political 
    subdivision to be considered an eligible applicant.
    
    Availability of Funds
    
        Approximately $1,000,000 is available in FY 1994 to fund 3-5 new 
    and competing awards. It is expected that the average award will be 
    $200,000, ranging from $100,000 to $300,000. It is expected that the 
    awards will begin on or about September 30, 1994, and will be made for 
    a 12-month budget period within a project period of up to 3 years.
        Continuation awards within the project period will be made on the 
    basis of satisfactory progress and the availability of funds.
    
    Purpose
    
        The purpose of this announcement is to solicit scientific proposals 
    designed to study the occurrence of/and risk factors for specified 
    health outcomes for persons who have had documented environmental 
    exposure to TCE through drinking or using contaminated water. The study 
    population will include all, or a subset, of the TCE Subregistry 
    registrants. These studies will increase the knowledge base, and hence 
    improve the ability of public health programs to address potential 
    public health problems related to exposure to hazardous substances.
        Several research topics were suggested based on the analysis of the 
    TCE Subregistry baseline data. The topics are to be considered 
    suggestions and not limitations. These topics are:
    
    --Hearing, speech impairment in subpopulation exposed at 10 
    years of age (neurological disorders)
    --Cardiac problems (possibly congenital) in subpopulation exposed at 
    10 years of age
    --Diabetes
    --Hypertension/stroke/heart problems in adult subpopulation
    
    Program Requirements
    
        The TCE baseline data and documentation are available on CD-ROM 
    (4.75 inch disc) which is accessed using the Statistical Export and 
    Tabulation System (SETS), data format ISO 9660. This can be run on a 
    fully IBM-compatible microcomputer 286/386/486 with 640K of memory, 
    three megabytes of free space on a hard drive, an operating system of 
    MS-DOS 3.1 or higher and a fully installed CD-Rom reader.
        Applicants must propose studies which will address one or more of 
    the following areas of investigation:
        A. Evaluate the occurrence of adverse health effects in the 
    identified population. This will include the evaluation of the 
    incidence or prevalence of a disease, disease symptoms, self-reported 
    health concerns, or biological markers of disease, susceptibility, or 
    exposure (see Purpose section for the specific disease outcomes 
    specified).
        B. Identify risk factors for adverse health effects in the 
    identified populations. This will include hypothesis generating cohort 
    or case-control studies on potentially impacted populations to identify 
    linkages between exposure and adverse health effects and those risk 
    factors which may be impacted by prevention actions. (See Purpose 
    section for a listing of the adverse health effects of concern.)
        C. Develop methods to diagnose adverse health effects (see Purpose 
    section for the adverse health effects of concern) in populations. This 
    will include medical research to evaluate currently available 
    biological tests (biomarkers) and disease occurrence in potentially 
    impacted populations.
        ATSDR will provide financial assistance to applicants in designing 
    and executing analytic epidemiologic studies to explore the 
    relationship between exposure to hazardous substances and the 
    occurrence of, and risk factors for, environmental exposure to TCE 
    through drinking and using contaminated water, using all or a subset of 
    the TCE Subregistry registrants.
        Applicants must specify the type of award for which they are 
    applying, either grant or cooperative agreement. These two types of 
    Federal assistance are explained below.
    
    A. Grants
    
        In a grant, the applicant will be required to conduct the proposed 
    study without substantial programmatic involvement by ATSDR. Grantees 
    must meet the following requirements: The application should be 
    presented in a manner that demonstrates the applicant's ability to 
    address the environmental health problems.
        The applicant's protocol should contain consent forms and 
    questionnaires, baseline morbidity and mortality information, 
    procedures for collecting biologic and environmental specimens and for 
    conducting laboratory analysis and evaluation of the test results of 
    biologic specimens, statistical and epidemiologic analysis of the study 
    information, and a description of the safeguards for protecting the 
    confidentiality of individuals on whom data are collected.
        By comparison, the activities of the recipient and the ATSDR for a 
    cooperative agreement are described in paragraph B.
    
    B. Cooperative Agreements
    
        In a cooperative agreement, ATSDR will assist the collaborator in 
    conducting the study. The application should be presented in a manner 
    that demonstrates the applicant's ability to address the health problem 
    in a collaborative manner with the funding agency. In conducting 
    activities to achieve the purpose of this program, the recipient shall 
    be responsible for the activities under 1., below and ATSDR shall be 
    responsible for conducting activities under 2., below:
    1. Recipient Activities
        a. Recipient will design, develop, and implement a protocol to 
    conduct the necessary study of exposed individuals.
        b. Recipient is required to provide proof, by citation of State 
    code or regulation or other State pronouncement given the authority of 
    law, that medical information obtained pursuant to the agreement, which 
    pertains to an individual and is therefore considered confidential, 
    will be protected from disclosure when the consent of the individual to 
    release identifying information is not obtained.
        c. If study requires knowledge of registrant personal identifiers, 
    recipient will develop a mechanism, working through ATSDR, for 
    interaction with the affected community to obtain necessary permission 
    for the release of this information to the recipient.
    2. ATSDR Activities
        a. ATSDR will assist in developing the study.
        b. ATSDR will provide epidemiologic and other technical assistance 
    in both the planning and implementation phases of the field work called 
    for under the study protocol.
        c. ATSDR will provide consultation and assist in monitoring the 
    collection and handling of information and the sampling and testing 
    activities.
        d. ATSDR will participate in the statistical and epidemiologic 
    analysis.
        e. ATSDR will collaborate in interpreting the study findings.
        f. ATSDR will assist (act as the intermediary) in obtaining 
    registrant permission for the release to the recipient of personal 
    information.
        g. ATSDR will conduct technical and peer review.
    
    Evaluation Criteria
    
        Applications will be reviewed and evaluated for scientific and 
    technical merit according to the following criteria:
    
    A. Scientific and Technical Review Criteria of New Applications
    
    1. Appropriateness and Knowledge of Study Design--25%
        The extent to which the applicant's proposal addresses: (a) 
    Rationale for the proposed study design; (b) the identification of a 
    target (exposed/diseased) population; (c) the identification of an 
    appropriate comparison group; (d) a consideration of sample size; (e) a 
    plan for exposure assessment and/or a plan for evaluating adverse 
    health outcomes; and (f) a detailed plan for analysis of the data.
    2. Proposed Study--25%
        The adequacy of the proposal relevant to: (a) The study purpose, 
    objectives, and rationale; (b) the quality of program objectives in 
    terms of specificity, measurability, and feasibility; (c) the 
    specificity and feasibility of the applicant's timetable for 
    implementing program activities and timely completion of the study; and 
    (d) the likelihood of the applicant agency completing proposed program 
    activities and attaining proposed objectives based on the thoroughness 
    and clarity of the overall program.
    3. Relationship to Initiative--15%
        The extent to which the application addresses the areas of 
    investigation outlined by ATSDR.
    4. Quality of Data Collection--15%
        The extent to which: (a) The study ascertains the information 
    necessary to meet the objectives, including (but not limited to) 
    information on pathways of exposure, confounding factors, and 
    biomedical testing; (b) the quality control and quality assurance of 
    questionnaire data are provided, including (but not limited to) 
    interviewer training and consistency checks of data; (c) the laboratory 
    tests (if applicable) are sensitive and specific for the analyte or 
    disease outcome of interest; and d) the quality control, quality 
    assurance, precision and accuracy of information for the proposed tests 
    are provided and acceptable.
        5. Applicant Capability and Coordination Efforts--10%
        The extent to which the proposal has described: (a) The capability 
    of the applicant's administrative structure to foster successful 
    scientific and administrative management of a study; (b) the capability 
    of the applicant to demonstrate an appropriate plan for interaction 
    with the community; and (c) the suitability of facilities and equipment 
    available or to be purchased for the project.
    6. Program Personnel--10%
        The extent to which the proposed program staff is qualified and 
    appropriate, and the time allocated for them to accomplish program 
    activities is adequate.
    7. Program Budget--(Not Scored)
        The extent to which the budget is reasonable, clearly justified, 
    and consistent with intended use of cooperative agreement/grant funds.
    
    B. Review of Continuation Applications
    
        Continuation awards within the project period will be made on the 
    basis of the following criteria:
        1. Satisfactory progress has been made in meeting project 
    objectives;
        2. Objectives for the new budget period are realistic, specific, 
    and measurable;
        3. Proposed changes in described long-term objectives, methods of 
    operation, need for grant support, and/or evaluation procedures will 
    lead to achievement of project objectives; and
        4. The budget request is clearly justified and consistent with the 
    intended use of grant funds.
    
    Executive Order 12372
    
        Applications are subject to the Intergovernmental Review of Federal 
    Programs as governed by Executive Order (E.O.) 12372. E.O. 12372 sets 
    up a system for State and local government review of proposed Federal 
    assistance applications. Applicants (other than federally-recognized 
    Indian tribal governments) should contact their State Single Point of 
    Contact (SPOC) as early as possible to alert them to the prospective 
    applications and receive any necessary instructions on the State 
    process. For proposed projects serving more than one State, the 
    applicant is advised to contact the SPOC for each affected State. A 
    current list of SPOCs is included in the application kit. If SPOCs have 
    any State process recommendations on applications submitted to CDC, 
    they should forward them to Henry S. Cassell, III, Grants Management 
    Officer, Grants Management Branch, Procurement and Grants Office, 
    Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry 
    Road, NE., room 300, Mailstop E-13, Atlanta, GA 30305, no later than 60 
    days after the application deadline. (By formal agreement, the CDC 
    Procurement and Grants Office will act on behalf of and for ATSDR on 
    this matter.) The granting agency does not guarantee to ``accommodate 
    or explain'' for State process recommendations it receives after that 
    date.
        Indian tribes are strongly encouraged to request tribal government 
    review of the proposed application. If tribal governments have any 
    tribal process recommendations on applications submitted to CDC, they 
    should forward them to Henry S. Cassell, III, Grants Management 
    Officer, Grants Management Branch, Procurement and Grants Office, 
    Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry 
    Road, NE., Mailstop E-13, Atlanta, GA 30305. This should be done no 
    later than 60 days after the application deadline date. The granting 
    agency does not guarantee to ``accommodate or explain'' for tribal 
    process recommendations it receives after that date.
    
    Public Health System Reporting Requirements
    
        This program is not subject to the Public Health System Reporting 
    Requirements.
    
    Catalog of Federal Domestic Assistance Number
    
        The Catalog of Federal Domestic Assistance number is 93.161.
    
    Other Requirements
    
    A. Protection of Human Subjects
    
        If the proposed project involves research on human subjects, the 
    applicant must comply with the Department of Health and Human Services 
    Regulation, 45 CFR part 46, regarding the protection of human subjects. 
    Assurances must be provided to demonstrate that the project will be 
    subject to initial and continuing review by an appropriate 
    institutional review committee. In addition to other applicable 
    committees, Indian Health Service (IHS) institutional review committees 
    also must review the project if any component of IHS will be involved 
    or will support the research. If any Native American community is 
    involved, its tribal government must also approve that portion of the 
    project applicable to it. The applicant will be responsible for 
    providing assurance in accordance with the appropriate guidelines and 
    form provided in the application kit.
    
    B. Cost Recovery
    
        The Comprehensive Environmental Response, Compensation, and 
    Liability Act (CERCLA) of 1980, as amended by the Superfund Amendments 
    and Reauthorization Act (SARA) of 1986, provides for the recovery of 
    costs incurred for health assessments and health effects studies at 
    each Superfund site from potentially responsible parties. The recipient 
    would agree to maintain an accounting system that will keep an 
    accurate, complete, and current accounting of all financial 
    transactions on a site-specific basis, i.e., individual time, travel, 
    and associated cost including indirect cost, as appropriate for the 
    site. The recipient would also maintain documentation that describes 
    the site-specific actions taken with respect to the site, e.g., 
    contracts, work assignments, progress reports, and other documents that 
    describe the work performed at a site. The recipient will retain the 
    documents and records to support these financial transactions, for 
    possible use in a cost recovery case, for a minimum of ten (10) years 
    after submission of a final Financial Status Report (FSR), unless there 
    is a litigation, claim, negotiation, audit or other action involving 
    the specific site, then the records will be maintained until resolution 
    of all issues on the specific site.
    
    C. Paperwork Reduction Act
    
        Projects that involve the collection of information from 10 or more 
    individuals and that are funded by the cooperative agreement mechanism 
    will be subject to review by the Office of Management and Budget (OMB) 
    under the Paperwork Reduction Act.
    
    D. Disclosure
    
        Recipient is required to provide proof by way of citation to State 
    code or regulation or other State pronouncement given the authority of 
    law, that medical information obtained pursuant to the agreement, 
    pertaining to an individual, and therefore considered confidential, 
    will be protected from disclosure when the consent of the individual to 
    release identifying information is not obtained.
    
    E. Third Party Agreements
    
        Project activities which are approved for contracting pursuant to 
    the prior approval provisions shall be formalized in a written 
    agreement that clearly establishes the relationship between the grantee 
    and the third party. The written agreement shall at a minimum:
        1. State or incorporate by reference all applicable requirements 
    imposed on the contractors under the grant by the terms of the grant, 
    including requirements concerning technical review (ATSDR selected 
    reviewers), release of data, ownership of data, and the arrangement for 
    copyright when publications, data or other copyrightable works are 
    developed under or in the course of work under a PHS grant supported 
    project or activity.
        2. State that any copyrighted or copyrightable works shall be 
    subject to a royalty-free, nonexclusive, and irrevocable license to the 
    Government to reproduce, publish, or otherwise use them, and to 
    authorize others to do so for Federal Government purposes.
        3. State that whenever any work subject to this copyright policy 
    may be developed in the course of a grant by a contractor under a 
    grant, the written agreement (contract) must require the contractor to 
    comply with these requirements and can in no way diminish the 
    Government's right in that work.
        4. State the activities to be performed, the time schedule for 
    those activities, the policies and procedures to be followed in 
    carrying out the agreement, and the maximum amount of money for which 
    the grantee may become liable to the third party under the agreement.
        5. The written agreement required shall not relieve the grantee of 
    any part of its responsibility or accountability to PHS under the 
    grant. The agreement shall, therefore, retain sufficient rights and 
    control to the grantee to enable it to fulfill this responsibility and 
    accountability.
    
    Application Submission and Deadline
    
        The original and two copies of the application PHS Form 5161-1 must 
    be submitted to Henry S. Cassell, III, Grants Management Officer, 
    Grants Management Branch, Procurement and Grants Office, Centers for 
    Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE., 
    room 300, Mailstop E-13, Atlanta, GA 30305, on or before July 21, 1994. 
    (By formal agreement, the CDC Procurement and Grants Office will act on 
    behalf of and for ATSDR on this matter.)
    
    1. Deadline
    
        Applications shall be considered as meeting the deadline if they 
    are either:
        a. Received on or before the deadline date, or
        b. Sent on or before the deadline date and received in time for 
    submission to the objective review group. (Applicants must request a 
    legibly dated U.S. Postal Service postmark or obtain a legibly dated 
    receipt from a commercial carrier or the U.S. Postal Service. Private 
    metered postmarks shall not be acceptable as proof of timely mailing.)
    
    2. Late Applications
    
        Applications which do not meet the criteria in 1.a. or 1.b. above 
    are considered late applications. Late applications will not be 
    considered in the current competition and will be returned to the 
    applicant.
    
    Where to Obtain Additional Information
    
        Additional information on application procedures, copies of 
    application forms, other material, and business management assistance 
    may be obtained from Maggie Slay, Grants Management Specialist, Grants 
    Management Branch, Procurement and Grants Office, Centers for Disease 
    Control and Prevention (CDC), 255 East Paces Ferry Road, NE., Mailstop 
    E-13, Atlanta, GA 30305, telephone (404) 842-6797. Programmatic 
    assistance may be obtained from Dr. Jeffrey A. Lybarger, Director, 
    Division of Health Studies, Agency for Toxic Substances and Disease 
    Registry, 1600 Clifton Road, NE., Mailstop E-31, Atlanta, GA 30333, 
    telephone (404) 639-6200.
        The complete technical report ``National Exposure Registry 
    Trichloroethylene (TCE) Subregistry Baseline Technical Report'' is 
    available through NTIS (# PB93-209187), May 1993. A summary of the 
    technical report, the ``Registrants Report'', and a copy of the 
    questionnaire used to collect the data is available through ATSDR 
    (request by calling Dr. JeAnne Burg, telephone (404) 639-6202.
        Please refer to Announcement Number 444 when requesting information 
    and submitting an application.
        Potential Applicants may obtain a copy of ``Healthy People 2000'' 
    (Full Report, Stock No. 017-001-00474-0) or ``Healthy People 2000'' 
    (Summary Report, Stock No. 017-001-00473-1) through the Superintendent 
    of Documents, Government Printing Office, Washington, DC 20402-9325, 
    telephone (202) 783-3238.
    
        Dated: May 27, 1994.
    Claire V. Broome,
    Acting Deputy Administrator, Agency for Toxic Substances and Disease 
    Registry.
    [FR Doc. 94-13505 Filed 6-2-94; 8:45 am]
    BILLING CODE 4163-70-P
    
    
    

Document Information

Published:
06/03/1994
Department:
Health and Human Services Department
Entry Type:
Uncategorized Document
Document Number:
94-13505
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: June 3, 1994